Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Synbio TechROCO:1295 -0.51%44 EBIT per Share is NT$6.47 as of Dec. 2025. GuruFocus rates ROCO:1295 with a GF Score™ of 44/100. The stock has 10 warning signs investors should review. Among 1,173 Biotechnology companies, Synbio Tech ranks better than 59.59% on this metric.
Synbio Tech's EBIT per Share for the
three
months ended in Dec. 2025 was NT$1.42.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 was NT$6.47.
During the past 12 months, the average EBIT per Share Growth Rate of Synbio Tech was -10.50% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 22.50% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 4.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Synbio Tech's EBIT per Share or its related term are showing as below:
ROCO:1295'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -3.5 Med: 3.6 Max: 22.5
Current: 22.5
During the past 6 years, the highest 3-Year average EBIT per Share Growth Rate of Synbio Tech was 22.50% per year. The lowest was -3.50% per year. And the median was 3.60% per year.
ROCO:1295's 3-Year EBIT Growth Rate is ranked better than 59.59% of 1173
companies
in the Biotechnology industry
Industry Median: 15.6
vs ROCO:1295: 22.50
Synbio Tech's EBIT for the
three
months ended in Dec. 2025 was NT$49 Mil.
Synbio Tech (ROCO:1295) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Synbio Tech EBIT per Share Related Terms
Synbio Tech EBIT per Share Historical Data
* Premium members only.
The historical data trend for Synbio Tech's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$6.47
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Synbio Tech (ROCO:1295) has a EBIT per Share of NT$6.47 as of Dec. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Synbio Tech and its competitors. According to the industry distribution chart, Synbio Tech ranks #474 out of 1173 companies in the Biotechnology industry, placing it in the top 40.4%.
Is Synbio Tech's EBIT per Share too high?
Synbio Tech's current EBIT per Share is NT$6.47. Based on the distribution chart, Synbio Tech ranks #474 out of 1173 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Synbio Tech has a GF Score™ of 44/100, reflecting its overall financial health beyond just this single metric.
How does Synbio Tech's EBIT per Share compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Synbio Tech ranks #474 out of 1173 companies for EBIT per Share. This puts Synbio Tech in the upper half of its industry. The industry median EBIT per Share is 15.60. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Biotechnology company?
The median EBIT per Share among Biotechnology companies is 15.60, based on 1,173 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Synbio Tech and its competitors. For the Biotechnology industry, the median EBIT per Share is 15.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Synbio Tech's current EBIT per Share is NT$6.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Synbio Tech stock overvalued right now?
Synbio Tech (ROCO:1295) has a current EBIT per Share of NT$6.47. The current EBIT per Share is NT$6.47. Synbio Tech's overall GF Score™ is 44/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Synbio Tech (ROCO:1295), the current EBIT per Share is NT$6.47 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Synbio Tech Inc focus on functional research and manufacturing of probiotics for human health and economic animals. It has two reportable segments, Taiwan and Mainland China Segment to engage in the production and R&D technologies of the Taiwan Segment, including the production and sales of concentrated fermentation liquid, lactobacillus plantarum solid drinks, and lactobacillus plantarum granules for animal husbandry. It generates majority of revenue from Taiwan segment includes production and sale of lactobacillus plantarum powder, lactobacillus plantarum fermentation derivative products, probiotics dietary supplements, probiotics products for pets and economic animals, and probiotics products. It has presence in Taiwan, China, Southeast Asia, and Others.
44GF Score
Get the complete analysis for ROCO:1295
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:1295 has been successfully added to your 
